Saturday, 27 Apr 2024

Contact details

Imperial College London,
510A,
ACE Extension,
South Kensington Campus,
180 Queen's Gate, South Kensington, London SW7 2AZ, UK
Go to Google Maps

Francesca Ceroni is currently Lecturer in the Department of Chemical Engineering at Imperial College London and member of the Imperial College Centre for Synthetic Biology Management Board. She graduated magna cum laude in Pharmaceutical Biotechnologies at the University of Bologna, and was awarded a PhD in Bioengineering from the same institution. After an experience as Post Doc in Italy, she moved to Imperial College London to join the lab of Prof Tom Ellis and Guy Bart Stan in the Dept of Bioengineering and work on the problem of cellular burden in bacterial cells. Soon after this, she was awarded a Junior Research Fellowship to start her independent career within the Dept of Chemical Engineering. Since October 2018 she is Lecturer in te same Department. Francesca is member of the World Economic Forum Expert Network.

PhD (Bioengineering) at the Alma Mater Studiorum – Università di Bologna, Italy. (2011)

MS Degree Pharmaceutical Biotechnologies (with Honours) Alma Mater Studiorum – Università di Bologna, Italy. (2007)

Bachelor`s Degree (Biotechnologies) (with Honours) Alma Mater Studiorum – Università di Bologna, Italy. (2004)

Junior Research Fellow, Department of Chemical Engineering, Imperial College London, 2016-2018

Research Associate, Department of Bioengineering, Imperial College London, 2013-2016

Research Fellow, European Brain Research Institute (EBRI), 2012

Post Doc, Alma Mater Studiorum – Università di Bologna, Italy, 2011

Visiting Research Fellow, Harvard Medical School, Boston (MA), 2010

Research in the Ceroni Lab is focused on bacterial and mammalian synthetic biology to expand the toolbox of available systems for control of gene expression and expand synthetic biology applications in cell therapy and bioproduction. In particular, the group has strong track record in the characterisation and measurement of cellular burden to achieve robust control of gene expression.

 

Latest by Francesca Ceroni